RxDoctor Payments Data

Ramanand Dandillaya, MD

Neurological Surgery · Santa Maria, CANPI 1508847187

Payments from drug & device makers

$1,545in general payments, 2019–2025

Across 37 payments — averaging $41.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$517
  • Biogen$120
  • Biotronik NRO, Inc.$99
  • Otsuka America Pharmaceutical, Inc.$95
  • Irhythm Technologies, Inc.$85
  • SK Life Science, Inc.$60
  • plus $569 from 17 others

What the payments were for

  • Food & beverage$1,39790%
  • Education$14810%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,545 in reported general payments places this provider in the 35th percentile of 773 neurological surgery providers in California.

See all neurological surgery providers in California

Medicare billing

Part B allowed, 2024
$15,151
Medicare patients
86
Services billed
93

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lacosamide59$6,661
Memantine Hcl274$5,800
Levetiracetam117$4,708
Carbamazepine27$3,171
Lamotrigine99$2,183
Carbamazepine ErCarbamazepine20$1,448
Donepezil Hcl114$1,272
Gabapentin66$1,253
Carbidopa-LevodopaCarbidopa/Levodopa36$1,211
Phenytoin Sodium Extended36$1,158
Topiramate43$936
Phenobarbital42$738
Oxcarbazepine19$716
Divalproex Sodium ErDivalproex Sodium17$691
Primidone51$674

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Santa Maria

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →